Validose

Brooklyn, NY · Founded 2017 · Privately Held (backing)

Developer of an intranasal drug delivery platform designed to deliver medication adherence solutions for clinical trials in real-time. Validose is based in Brooklyn, NY and was founded in 2017. It was valued at $6 million at its seed round in Jan 2025, the last priced event on record. It has raised $2 million across 1 recorded round; the latest was a $1.6 million seed round in Dec 2024.

PMV mark · valuation
$6.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$2.0M
Last round
Seed Round
Dec 2024
How much has Validose raised?
$2.0Macross 1 recorded rounds · Dec 2024 – Dec 2024

Most recently, Validose raised $1.6M in its Seed Round (Dec 2024).

Free account
More of Validose with a free account
  • ·Watch Validose: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Validose round by round

1 rounds
Dec 2024Seed Round$1.6MSEC filing▮
2 investors participated

How much has Validose raised?

Validose has raised $2 million across 1 recorded round since 2024. The largest was a $1.6 million seed round in Dec 2024.

Validose has filed 1 Form D with the SEC, most recently in Jan 2025 ($1.6 million sold to 2 investors).

Validose investors

3 investors are on record for Validose, including Interstate Fusion Ventures, Bauer Family Office's Technology for Humanity and 10XBeta. By type, the record holds 3 venture capital firms. The seed round in Dec 2024 drew 2 investors.

For fundraisers
Raising for a company like Validose?

3 investors have backed Validose.

See all 3 investors →

Frequently asked about Validose

How much has Validose raised?
Validose has raised $2.0M in total across 1 recorded funding rounds.
When was Validose's last funding round?
Validose's most recent recorded round was Seed Round in Dec 2024, raising $1.6M.